59
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Characterization of mumps virus strains with varying neurovirulence

, , &
Pages 330-337 | Received 25 Aug 2004, Accepted 27 Jan 2005, Published online: 08 Jul 2009

References

  • AfZal MA, Yates PJ, Minor PD. Nucleotide sequence at position 1081 of the haemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. J Infect Dis 1998;177: 265–6.
  • Amexis G, Rubin S, Chatterjee N, Carbone K, Chumakov K. Identification of a new genotype H wild-type mumps virus strain and its molecular relatedness to other virulent and attenuated strains. J Med Virol 2003;70:284–6.
  • Brown EG, Dimock K, Wright KE. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the haemagglutinin-neuraminidase gene with 1 form associated with disease. J Infect Dis 1996;174: 619–22.
  • Carbone KM, Wolinsky JS. Mumps virus. Chapter 44, Fields Virology, Fourth Edition 2000;1381–1400.
  • Garzia Cusi M, Santani L, Bianchi S, Valassina M, Valensin PE. Nucleotide sequence at position 1081 of the haemag- glutinin-neuramidase gene in wild-type strains of mumps virus is the most relevant marker of virulence. J Clin Microbiol 1998;36: 3743–4.
  • Inou Y, Nakayama T, Yoshida N, Uejima H, Yuri K, Kamada M, et al. Molecular epidemiology of mumps virus in Japan and proposal of 2 new genotypes. J Med Virol 2004;73:97–104.
  • Jin L, Brown DW, Litton PA, White JM. Genetic diversity of mumps virus in oral fluid specimens: application to mumps epidemiological study. J Infect Dis 2004;189:1001–8.
  • Kövamees J, Rydbeck R, Örvell C, Norrby E. Haemagglu- tinin-neuraminidase (HN) 12. amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res 1990;17: 119–29.
  • Löve A, Rydbeck R, Kristensson K, Örvell C, Norrby E. Haemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. J Virol 1985;53:67–74.
  • Merz DC, Wolinsky JS. Biochemical features of mumps virus neuraminidases and their relationship with pathogenicity. Virology 1981;114:218–27.
  • Nöjd J, Tecle T, Samuelson A, Örvell C. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 2001; 19:1727–31.
  • Örvell C, Kalantari M, Johansson B. Characterization of 5 conserved genotypes of the mumps virus small hydrophobic (SH) protein gene. J Gen Virol 1997;78: 91–5.
  • Örvell C, Alsheikhly AR, Kalantari M, Johansson B. Characterization of genotype-specific epitopes of the HN protein of mumps virus. J Gen Virol 1997;78:3187–93.
  • Örvell C, Tecle T, Johansson B. Mumps virus: an underestimated viral pathogen. Current Topics in Virol 2002; 2:100–13.
  • Örvell C, Tecle T, Johansson B, Saito H, Samuelson A. Antigenic relationships between 6 genotypes of the small hydrophobic protein gene of mumps virus. J Gen Virol 2002; 83:2489–6.
  • Rubin SA, Pletnikov M, Taffs R, Snoy PJ, Kobasa D, Brown EG, et al. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J Virol 2000; 74:5382–4.
  • Rubin SA, Amexis G, Pletnikov M, Li Z, Vanderzanden J, Mauldin J, et al. Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J Virol 2003;77:11616–24.
  • Saika S, Kidokoro M, Öhkawa T, Aoki A, Suzuki K. Pathogenicity of mumps virus in the marmoset. J Med Virol 2002;66:115–22.
  • Saito H, Takahashi Y, Harata S, Tanaka K, Sano T, Suto T, et al. Isolation and characterization of mumps virus strains in a mumps outbreak with a high incidence of aseptic menigitis. Microbiol Immunol 1996;40:271–5.
  • Saito H, Takahashi Y, Harata S, Tanaka K, Sato H, Suto T, et al. Cloning and characterization of the genomic RNA sequence of the mumps virus strain associated with a high incidence of aseptic meningitis. Microbiol Immunol 1998; 42:133–7.
  • Takeuchi K, Tanabayashi K, Hishiyama M, Sugiura A. Cloning and sequencing of the fusion protein gene of mumps virus (Miyahara strain). Nucleic Acids Res 1998;17:5839.
  • Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A. The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology 1996;225:156–62.
  • Tanabayashi K, Takeuchi K, Ökazaki K, Hishiyama M, Yamada A. Identification of an amino acid that defines the fusogenicity of mumps virus. J Virol 1993;67:2928–31.
  • Tanabayashi K, Takeuchi K, Hishiyama M, Yamada A. Effect on fusion induction of point mutations introduced into the F protein of mumps virus. Virology 1994;204: 851–3.
  • Tecle T, Johansson B, Jejcic A, Forsgren M, Örvell C. Characterization of 3 cocirculating genotypes of the small hydrophobic protein gene of mumps virus. J Gen Virol 1998;79: 2929–37.
  • Tecle T, Johansson B, Yun Z, Örvell C. Antigenic and genetic characterization of the fusion (F) protein of mumps virus strains. Arch Virol 2000;145:1199–210.
  • Tecle T, Böttiger B, Örvell C, Johansson B. Characterization of 2 decades of temporal cocirculation of 4 mumps virus genotypes in Denmark: identification of a new genotype J Gen Virol 2001;82: 2675–80.
  • Tecle T, Mickiene A, Johansson B, Lindquist L, Örvell C. Molecular characterization of 2 mumps virus genotypes circulating during an epidemic in Lithuania from 1998 to 2000. Arch Virol 2002;147: 243–53.
  • Uchida K, Shinohara M, Shimada S, Segawa Y, Kimura K, Hoshino Y. Characterization of the F gene of contemporary mumps virus strains isolated in Japan. Microbiol Immunol 2003;47:167–72.
  • Utz S, Richard JL, Capul S, Matter HC, Hrisoho MG, Muhlemann K. Phylogenetic analysis of clinical mumps virus isolates from vaccinated and non-vaccinated patients with mumps during an outbreak, Switzerland 1998–2000. J Med Virol 2004;73:91–6.
  • van de Peer Y, De Wachter R. TREECÖN for Windows: a software package for the construction and drawing of evolutionary trees for the MICRÖSÖFT Windows Environment: Appl Biosci 1994;10:569–70.
  • Yates PJ, Afzal MA, Minor PD. Antigenic and genetic variation of the HN protein of mumps virus strains. J Gen Virol 1996; 77:371–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.